Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jul;74(1):59–62. doi: 10.1038/bjc.1996.315

An analysis of surveillance for stage I combined teratoma--seminoma of the testis.

R Thomas 1, D Dearnaley 1, J Nicholls 1, A Norman 1, S Sampson 1, A Horwich 1
PMCID: PMC2074607  PMID: 8679458

Abstract

We analysed 973 patients with stage I testicular tumours presenting between 1983 and 1994. The median ages at presentation for non-seminomatous germ cell tumour (teratoma) were 27 years, seminoma 36 years and combined tumour 33 years. These differences were statistically significant (Mann-Whitney P < 0.05), suggesting that combined tumours may have a separate natural history. We, therefore, analysed all stage I patients managed with surveillance (530 in total) post orchidectomy. The actuarial 5 year relapse-free survival and anatomical patterns of relapse were identical for non-seminomatous germ cell tumour (NSGCT) and combined tumour and both were statistically distinct from seminoma (P = 0.01, log-rank test, chi-square test P = 0.001). The association of seminoma within a histologically confirmed NSGCT has no influence on the clinical outcome.

Full text

PDF
59

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Duchesne G. M., Horwich A., Dearnaley D. P., Nicholls J., Jay G., Peckham M. J., Hendry W. F. Orchidectomy alone for stage I seminoma of the testis. Cancer. 1990 Mar 1;65(5):1115–1118. doi: 10.1002/1097-0142(19900301)65:5<1115::aid-cncr2820650513>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  2. Freedman L. S., Parkinson M. C., Jones W. G., Oliver R. T., Peckham M. J., Read G., Newlands E. S., Williams C. J. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987 Aug 8;2(8554):294–298. doi: 10.1016/s0140-6736(87)90889-0. [DOI] [PubMed] [Google Scholar]
  3. Hamilton C. R., Horwich A., Bliss J. M., Peckham M. J. Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. Radiother Oncol. 1987 Oct;10(2):85–90. doi: 10.1016/s0167-8140(87)80049-x. [DOI] [PubMed] [Google Scholar]
  4. Hamilton C., Horwich A., Easton D., Peckham M. J. Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol. 1986 Jun;6(2):115–120. doi: 10.1016/s0167-8140(86)80017-2. [DOI] [PubMed] [Google Scholar]
  5. Hoeltl W., Pont J., Kosak D., Honetz N., Marberger M. Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion". Br J Urol. 1992 Jan;69(1):83–87. doi: 10.1111/j.1464-410x.1992.tb15465.x. [DOI] [PubMed] [Google Scholar]
  6. Horwich A., Alsanjari N., A'Hern R., Nicholls J., Dearnaley D. P., Fisher C. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer. 1992 May;65(5):775–778. doi: 10.1038/bjc.1992.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Horwich A., Bell J. Mortality and cancer incidence following radiotherapy for seminoma of the testis. Radiother Oncol. 1994 Mar;30(3):193–198. doi: 10.1016/0167-8140(94)90457-x. [DOI] [PubMed] [Google Scholar]
  8. Horwich A. Current issues in the management of clinical stage I testicular teratoma. Eur J Cancer. 1993;29A(7):933–934. doi: 10.1016/s0959-8049(05)80195-9. [DOI] [PubMed] [Google Scholar]
  9. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ray B., Hajdu S. I., Whitmore W. F., Jr Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer. 1974 Feb;33(2):340–348. doi: 10.1002/1097-0142(197402)33:2<340::aid-cncr2820330207>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  11. Read G., Stenning S. P., Cullen M. H., Parkinson M. C., Horwich A., Kaye S. B., Cook P. A. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol. 1992 Nov;10(11):1762–1768. doi: 10.1200/JCO.1992.10.11.1762. [DOI] [PubMed] [Google Scholar]
  12. Thomas G. M., Sturgeon J. F., Alison R., Jewett M., Goldberg S., Sugar L., Rideout D., Gospodarowicz M. K., Duncan W. A study of post-orchiectomy surveillance in stage I testicular seminoma. J Urol. 1989 Aug;142(2 Pt 1):313–316. doi: 10.1016/s0022-5347(17)38742-6. [DOI] [PubMed] [Google Scholar]
  13. Williams S. D., Stablein D. M., Einhorn L. H., Muggia F. M., Weiss R. B., Donohue J. P., Paulson D. F., Brunner K. W., Jacobs E. M., Spaulding J. T. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med. 1987 Dec 3;317(23):1433–1438. doi: 10.1056/NEJM198712033172303. [DOI] [PubMed] [Google Scholar]
  14. von der Maase H., Specht L., Jacobsen G. K., Jakobsen A., Madsen E. L., Pedersen M., Rørth M., Schultz H. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer. 1993;29A(14):1931–1934. doi: 10.1016/0959-8049(93)90446-m. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES